All are associated with MEN 2 except:
**Core Concept**
Multiple Endocrine Neoplasia type 2 (MEN 2) is a rare genetic disorder characterized by the occurrence of tumors in multiple endocrine glands. It is primarily associated with mutations in the RET proto-oncogene, leading to the development of medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. The clinical manifestations of MEN 2 are a result of the abnormal function of these endocrine glands.
**Why the Correct Answer is Right**
Islet cell hyperplasia is not a characteristic feature of MEN 2. MEN 2 is primarily associated with the development of medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. Islet cell hyperplasia is more commonly associated with MEN 1, another form of multiple endocrine neoplasia. In MEN 1, islet cell hyperplasia can lead to the development of pancreatic neuroendocrine tumors, including gastrinomas and insulinomas. The RET proto-oncogene mutation responsible for MEN 2 is not associated with islet cell hyperplasia.
**Why Each Wrong Option is Incorrect**
**Option A:** Pheochromocytoma is a characteristic feature of MEN 2, particularly MEN 2A and MEN 2B. It is a tumor of the adrenal gland that can lead to the excessive production of catecholamines, resulting in hypertension and other systemic symptoms.
**Option C:** Medullary carcinoma of the thyroid is a hallmark of MEN 2. It is a tumor of the parafollicular cells of the thyroid gland, which can produce calcitonin and other peptides. MEN 2 is the primary cause of medullary thyroid carcinoma in most cases.
**Option D:** Primary hyperparathyroidism is a common feature of MEN 2, particularly MEN 2A. It is caused by the development of parathyroid gland tumors that produce excess parathyroid hormone, leading to hypercalcemia and other systemic symptoms.
**Clinical Pearl / High-Yield Fact**
MEN 2 is a hereditary disorder that can be inherited in an autosomal dominant pattern. Patients with MEN 2 should undergo regular screening for the development of medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. Early detection and treatment can significantly improve outcomes in patients with MEN 2.
**✓ Correct Answer: B. Islet cell hyperplasia**